Riverstone Advisors, LLC Dexcom Inc Transaction History

Riverstone Advisors, LLC

$185 Million
Q2 2025

A detailed history of Riverstone Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Riverstone Advisors, LLC holds 8,194 shares of DXCM stock, worth $543,508. This represents 0.39% of its overall portfolio holdings.

Number of Shares

8,194

Previous 10,844 24.44%

Holding current value

$543,508

Previous $740,000 3.38%

% of portfolio

0.39%

Previous 0.45%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$59.83 - $87.57 $158,549 - $232,060	-2,650 Reduced 24.44%	8,194 $715,000
Q1 2025 Apr 25, 2025	SELL	$67.74 - $90.75 $387,540 - $519,180	-5,721 Reduced 34.54%	10,844 $740,000
Q4 2024 Jan 24, 2025	SELL	$65.68 - $81.01 $176,482 - $217,673	-2,687 Reduced 13.96%	16,565 $1.29 Million
Q3 2024 Nov 04, 2024	SELL	$64.0 - $116.06 $164,224 - $297,809	-2,566 Reduced 11.76%	19,252 $1.29 Million
Q2 2024 Jul 19, 2024	SELL	$110.31 - $140.45 $2.55 Million - $3.25 Million	-23,160 Reduced 51.49%	21,818 $2.47 Million
Q1 2024 May 10, 2024	SELL	$114.22 - $140.1 $258,137 - $316,626	-2,260 Reduced 4.78%	44,978 $6.24 Million
Q4 2023 Jan 30, 2024	SELL	$75.49 - $124.16 $228,885 - $376,453	-3,032 Reduced 6.03%	47,238 $5.86 Million
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $83,994 - $134,619	-976 Reduced 1.9%	50,270 $4.69 Million
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $86,152 - $100,330	-766 Reduced 1.47%	51,246 $6.59 Million
Q1 2023 May 02, 2023	BUY	$104.0 - $122.92 $218,192 - $257,886	2,098 Added 4.2%	52,012 $6.04 Million
Q4 2022 Jan 31, 2023	SELL	$84.98 - $122.67 $61,015 - $88,077	-718 Reduced 1.42%	49,914 $5.65 Million
Q3 2022 Oct 27, 2022	SELL	$76.35 - $94.18 $372,893 - $459,975	-4,884 Reduced 8.8%	50,632 $4.08 Million
Q2 2022 Jul 26, 2022	BUY	$67.99 - $132.89 $2.83 Million - $5.53 Million	41,644 Added 300.2%	55,516 $4.14 Million
Q1 2022 Apr 29, 2022	SELL	$94.08 - $130.2 $6,209 - $8,593	-66 Reduced 0.47%	13,872 $7.1 Million
Q4 2021 Jan 26, 2022	BUY	$129.87 - $162.82 $42,857 - $53,730	330 Added 2.43%	13,938 $7.48 Million
Q3 2021 Nov 04, 2021	BUY	$106.71 - $143.18 $35,107 - $47,106	329 Added 2.48%	13,608 $7.44 Million
Q2 2021 Jul 28, 2021	BUY	$80.99 - $107.93 $10,366 - $13,815	128 Added 0.97%	13,279 $5.67 Million
Q1 2021 Apr 26, 2021	BUY	$84.79 - $104.74 $75,039 - $92,694	885 Added 7.22%	13,151 $4.73 Million
Q4 2020 Feb 02, 2021	BUY	$78.0 - $104.5 $510,198 - $683,534	6,541 Added 114.25%	12,266 $4.54 Million
Q3 2020 Oct 28, 2020	BUY	$95.51 - $112.95 $110,409 - $130,570	1,156 Added 25.3%	5,725 $2.36 Million
Q2 2020 Jul 22, 2020	BUY	$62.68 - $105.34 $286,384 - $481,298	4,569 New	4,569 $1.85 Million

Others Institutions Holding DXCM

# of Institutions

1,108

Shares Held

368M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverstone Advisors, LLC with notifications on news.

Account

Riverstone Advisors, LLC Dexcom Inc Transaction History